A Clinical Study on the effect of Nagaradi Kwatha in the management of Grahani Roga with special reference to Malabsorption Syndrome

Department of Kayacikitsa0 个研究点目标入组 47 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients willing to participate in the study.
•2.Patients having the classical features of Grahani roga alongwith reduced appetite, tenesmus, and frequent passage of loose, mucoid stools.
•4.Total duration of the illness less than one year.

•1.Patients not willing to participate in the study.
•2.Patients of either sex below 30 year and above 65 years will be excluded from the study.
•3.Patients with features of Sangraha grahani, Ghateeyantra grahani and evidence of malignancy, ulcerative colitis, Crohnâ??s disease, abdominal TB.
•4.Total duration of the illness more than three years.
•5.Patients on prolonged ( >6weeks) medication with corticosteroids, anti-depressants, anticholinergics, etc., or any other drugs that may have an influence on the outcome of the study.
•6.Patients suffering from major systemic illness necessitating long term drug treatment Rheumatoid arthritis, tuberculosis, psycho-neuro-endocrinal disorders, etc.
•7.Patients with concurrent serious hepatic disorder or renal disorders, severe pulmonary dysfunction, major cardiac problems or any other condition that may jeopardize the study.
•8.Alcoholics and/or drug abusers.
•9.History of hypersensitivity to the trial drug or any of its ingredients.
•10.Pregnant/ lactating woman.
•11.Patients who have completed participation in any other clinical trial during the past 6 months.
•12.Any other conditions, which the principal investigator thinks may exclude the patient.

发起方

Department of Kayacikitsa